Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Baynes Roy D.
Director at Travere Therapeutics · Director at Natera. Filing since 7 Aug 2020.
CIK 0001680739
TVTX
Travere Therapeutics, Inc.
Director · 7 trades
NTRA
Natera, Inc.
Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX
Travere Therapeutics, Inc.
12 Jun 2026
Director
Sold on a plan
4,500
$225.00K
9.8%
TVTX
Travere Therapeutics, Inc.
5 May 2026
Director
Sold on a plan
4,500
$209.93K
10.7%
TVTX
Travere Therapeutics, Inc.
1 May 2026
Director
Sold on a plan
9,750
$431.15K
20.6%
TVTX
Travere Therapeutics, Inc.
14 Apr 2026
Director
Sold on a plan
32,750
$1.35M
46.6%
TVTX
Travere Therapeutics, Inc.
6 Apr 2026
Director
Sold on a plan
10,000
$330.00K
21.1%
NTRA
Natera, Inc.
20 Nov 2025
Director
Sold on a plan
7,668
$1.71M
29.5%
NTRA
Natera, Inc.
19 Nov 2025
Director
Sold on a plan
5,112
$1.10M
21.8%
TVTX
Travere Therapeutics, Inc.
6 Feb 2025
Director
Sold on a plan
10,000
$220.00K
24.4%
TVTX
Travere Therapeutics, Inc.
23 Jan 2025
Director
Sold on a plan
16,000
$320.00K
34.0%
NTRA
Natera, Inc.
15 Nov 2024
Director
Sold on a plan
37,230
$5.44M
70.2%
NTRA
Natera, Inc.
7 Aug 2020
Director
Sold, plan not stated
1,300
$69.51K
100%
11 decisions on file.
